Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3355 |
|
Actual shortage: | 217 (6%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 335 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
61 (25%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Resolved | 2023-09-28 | 2023-10-27 | 205492 |
APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Resolved | 2022-08-09 | 2022-09-23 | 166402 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Resolved | 2024-05-10 | 2024-06-14 | 227722 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Resolved | 2024-10-31 | 2024-11-29 | 241697 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Resolved | 2021-07-23 | 2021-09-14 | 142967 |
APO-ACYCLOVIR | 200MG | TABLET | Resolved | 2022-04-08 | 2022-04-13 | 158339 |
APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2022-04-08 | 2022-05-25 | 158345 |
APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2017-07-26 | 2017-12-31 | 17198 |
APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2021-11-26 | 2022-01-21 | 150049 |
APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174642 |
APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2018-01-17 | 2018-01-31 | 36257 |
APO-ACYCLOVIR | 200MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174636 |
APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2018-03-05 | 2018-07-03 | 41841 |
APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2022-04-08 | 2022-04-13 | 158342 |
APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2023-09-01 | 2024-10-11 | 203566 |
APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2019-07-12 | 2019-08-31 | 89152 |
APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174639 |
APO-ACYCLOVIR | 200MG | TABLET | Resolved | 2018-03-05 | 2018-07-03 | 41834 |
APO-ACYCLOVIR | 200MG | TABLET | Resolved | 2017-09-04 | 2017-12-31 | 20857 |
APO-ACYCLOVIR | 200MG | TABLET | Resolved | 2017-03-11 | 2017-04-21 | 630 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |